EUGENIE S KLEINERMAN to Immunotherapy, Active
This is a "connection" page, showing publications EUGENIE S KLEINERMAN has written about Immunotherapy, Active.
Connection Strength
0.009
-
Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma. J Immunother Emphasis Tumor Immunol. 1996 May; 19(3):206-17.
Score: 0.009